Molecular recognition mechanisms for detecting cell death in vivo

Current Pharmaceutical Biotechnology

Volumn 11, Issue 6, 2010, Pages 693-700

  Zhao, Ming ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Apoptosis; Imaging; Necrosis; Probe

Indexed keywords

CASPASE; CASPASE 10; CASPASE 2; CASPASE 3; CASPASE 6; CASPASE 7; CASPASE 8; CASPASE 9; COMPLEMENT COMPONENT C2A; LANCOVUTIDE; LANTHIOPEPTIN; LIPOCORTIN 5; MEMBRANE PHOSPHOLIPID; METHYLMALONIC ACID; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLSERINE; SYNAPTOTAGMIN I; BIOLOGICAL MARKER; DIAGNOSTIC AGENT;

APOPTOSIS; BINDING AFFINITY; BINDING SITE; CELL DEATH; CHEMICAL MODIFICATION; CROSS LINKING; DISEASE MARKER; ENZYME ACTIVITY; ENZYME LOCALIZATION; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; IN VIVO STUDY; ISOTOPE LABELING; MOLECULAR RECOGNITION; MOLECULAR WEIGHT; PROTEIN BINDING; PROTEIN DOMAIN; REVIEW; SCINTISCANNING; SIGNAL TRANSDUCTION; ANIMAL; GENETIC PROCEDURES; METABOLISM; METHODOLOGY; MOLECULAR IMAGING; MOLECULAR PROBE; PHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY;

ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; HUMANS; MOLECULAR IMAGING; MOLECULAR PROBE TECHNIQUES; MOLECULAR PROBES; POSITRON-EMISSION TOMOGRAPHY;

EID: 79952115191     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920110792246591     Document Type: Review

References (87)

1. Song, Z.; Steller, H. Death by design: mechanism and control of apoptosis. Trends Cell Biol., 1999, 9. M49-52.
2. Wyllie, A.H. Apoptosis: an overview. Br. Med. Bull., 1972, 53. 451-465.
3. Kerr, J.F.; Wyllie, A.H.; Currie, A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer. 1997, 26. 239-257.
4. Grutter, M.G. Caspases: key players in programmed cell death. Curr. Opin. Struct. Biol., 2000, 10. 649-655.
5. Green, D.R. Apoptotic pathways: the roads to ruin. Cell. 1998, 94. 695-698.
6. Holman, B.L. Radionuclide methods in the evaluation of myocardial ischemia and infarction. Circulation. 1976, 53(3 Suppl I1), 12-119.
7. Parkey, R.W.; Bonte, F.J.; Buja, L.M.; Stokely, E.M.; Willerson JT. Myocardial infarct imaging with technetium-99m phosphates. Semin. Nucl. Med., 1977, 7. 15-28.
8. Ohtani, H.; Callahan, R.J.; Khaw, B.A.; Fishman, A.J.; Wilkinson, R.A.; Strauss, H.W. Comparison of technetium-99m-glucarate and thallium-201 for the identification of acute myocardial infarction in rats. J. Nucl. Med., 1992, 33. 1988-1993.
9. 99mTc-labeled glucarate. Circulation. 1997, 95. 1577-1584.
10. Khaw, B.A.; Strauss, H.W.; Pohost, G.M.; Fallon, J.T.; Katus, H.A.; Haber, E. Relation of immediate and delayed thallium-201 distribution to localization of iodine-125 antimyosin antibody in acute experimental myocardial infarction. Am. J. Cardiol., 1983, 51. 1428-32.
11. Khaw, B.A.; Gold, H.K.; Yasuda, T.; Leinbach, R.C.; Kanke, M.; Fallon, J.T.; Barlai-Kovach, M.; Strauss, H.W.; Sheehan, F.; Haber E. Scintigraphic quantification of myocardial necrosis in patients after intravenous injection of myosin-specific antibody. Circulation. 1986, 74. 501-508.
12. Thornberry, N.A.; Lazebnik, Y. Caspases: enemies within. Science, 1998, 281. 1312-1316.
13. Greenberg, A.H. Granzyme B-induced apoptosis. Adv. Exp. Med. Biol., 1996, 406. 219-228.
14. Thornberry, N.A.; Rano, T.A.; Peterson, E.P.; Rasper, D.M.; Timkey, T.; Garcia-Calvo, M.; Houtzager, V.M.; Nordstrom, P.A.; Roy, S.; Vaillancourt, J.P.; Chapman, K.T.; Nicholson DW. A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J. Biol. Chem., 1997, 272. 17907-17911.
15. Nicholson, D.W. Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ., 1999, 6. 1028-1042.
16. Stennicke, H.R.; Salvesen, G.S. Catalytic properties of the caspases. Cell Death Differ., 1999, 6. 1054-1059.
17. Margolin, N.; Raybuck, S.A.; Wilson, K.P.; Chen, W.; Fox, T.; Gu, Y.; Livingston, D.J. Substrate and inhibitor specificity of interleukin-1 beta-converting enzyme and related caspases. J. Biol. Chem., 1997, 272. 7223-7228.
18. Xu, X.; Gerard, A.L.; Huang, B.C.; Anderson, D.C.; Payan, D.G.; Luo, Y. Detection of programmed cell death using fluorescence energy transfer. Nucleic Acids Res., 1998, 26. 2034-2035.
19. Jones, J.; Heim, R.; Hare, E.; Stack, J.; Pollok, B.A. Development and application of a GFP-FRET intracellular caspase assay for drug screening. J. Biomol. Screen., 2000, 5. 307-318.
20. Harpur, A.G.; Wouters, F.S.; Bastiaens, P.I. Imaging FRET between spectrally similar GFP molecules in single cells. Nat. Biotechnol., 2001, 19, 167-169.
21. Nguyen, A.W.; Daugherty, P.S. Evolutionary optimization of fluorescent proteins for intracellular FRET. Nat. Biotechnol., 2005, 23. 355-360.
22. Luo, K.Q.; Yu, V.C.; Pu, Y.; Chang, D.C. Application of the fluorescence resonance energy transfer method for studying the dynamics of caspase-3 activation during UV-induced apoptosis in living HeLa cells. Biochem. Biophys. Res. Commun., 2001, 283, 1054-1060.
23. Rehm, M.; Dussmann, H.; Janicke, R.U.; Tavare, J.M.; Kogel. D.; Prehn, J.H. Single-cell fluorescence resonance energy transfer analysis demonstrates that caspase activation during apoptosis is a rapid process. Role of caspase-3. J. Biol. Chem., 2002, 277. 24506-24514.
24. Onuki, R.; Nagasaki, A.; Kawasaki, H.; Baba, T.; Uyeda, T.Q.; Taira, K. Confirmation by FRET in individual living cells of the absence of significant amyloid beta-mediated caspase 8 activation. Proc. Natl. Acad. Sci. USA, 2002, 99, 14716-14721.
25. Luo, K.Q.; Yu, V.C.; Pu, Y.; Chang, D.C. Measuring dynamics of caspase-8 activation in a single living HeLa cell during TNFalphainduced apoptosis. Biochem. Biophys. Res. Commun., 2003, 304. 217-222.
26. Peng, X.; Chen, H.; Draney, D.R.; Volcheck, W.; Schutz-Geschwender, A.; Olive, D.M. A nonfluorescent, broad-range quencher dye for Förster resonance energy transfer assays. Anal. Biochem. 2009, 388. 220-228.
27. Zhou. F.; Xing, D.; Wu, S.; Chen, W.R. Intravital Imaging of tumor apoptosis with FRET probes during tumor therapy. Mol. Imaging Biol., 2010, 12. 63-70.
28. Zhang, Z.; Fan, J.; Cheney, P.P.; Berezin, M.Y.; Edwards, W.B.; Akers, W.J.; Shen, D.; Liang, K.; Culver, J.P.; Achilefu, S. Activatable molecular systems using homologous near-infrared fluorescent probes for monitoring enzyme activities in vitro. in cellulo, and in vivo. Mol. Pharm., 2009, 6. 416-427.
29. Keese, M.; Yagublu, V.; Schwenke, K.; Post, S.; Bastiaens, P. Fluorescence lifetime imaging microscopy of chemotherapyinduced apoptosis resistance in a syngenic mouse tumor model. Int. J. Cancer. 2010, 126. 104-113.
30. Messerli, S.M.; Prabhakar, S.; Tang, Y.; Shah, K.; Cortes, M.L.; Murthy, V.; Weissleder, R.; Breakefield, X.O.; Tung, C.H. A novel method for imaging apoptosis using a caspase-1 near-infrared fluorescent probe. Neoplasia. 2004, 6, 95-105.
31. Zhou, D.; Chu, W.; Chen, D.L.; Wang, Q.; Reichert, D.E.; Rothfuss, J.; D'Avignon, A.; Welch, M.J.; Mach, R.H. [18F]-and [11C]-labeled N-benzyl-isatin sulfonamide analogues as PET tracers for apoptosis: synthesis, radiolabeling mechanism, and in vivo imaging study of apoptosis in Fas-treated mice using [11C]WC-98. Org. Biomol. Chem., 2009, 7. 1337-1348.
32. Faust, A.; Wagner, S.; Law, M.P.; Hermann, S.; Schnöckel, U.; Keul, P.; Schober, O.; Schäfers, M.; Levkau, B.; Kopka K. The nonpeptidyl caspase binding radioligand (S)-1-(4-(2-18F Fluoroethoxy)-benzyl)-5-1-(2-methoxymethylpyrrolidinyl)sulfonyl isatin ([18F]CbR) as potential positron emission tomographycompatible apoptosis imaging agent. Q. J. Nucl. Med. Mol. Imaging, 2007, 51. 67-73.
33. Podichetty, A.K.; Wagner, S.; Schröer, S.; Faust, A.; Schäfers, M.; Schober, O.; Kopka, K.; Haufe, G. Fluorinated isatin derivatives. Part 2. New N-substituted 5-pyrrolidinylsulfonyl isatins as potential tools for molecular imaging of caspases in apoptosis. J. Med. Chem. 2009, 52. 3484-3495.
34. Smith, G.; Glaser, M.; Perumal, M.; Nguyen, Q.D.; Shan, B.; Arstad, E.; Aboagye, E.O. Design, synthesis, and biological characterization of a caspase 3/7 selective isatin labeled with 2-[18F]fluoroethylazide. J. Med. Chem., 2008, 51. 8057-8067.
35. Gao, M.; Wang, M.; Miller, K.D.; Hutchins, G.D.; Zheng, Q.H. Synthesis of carbon-11-labeled 4-aryl-4H-chromens as new PET agents for imaging of apoptosis in cancer. Appl. Radiat. Isot. 2010, 68. 110-611.
36. Nguyen, Q.D.; Smith, G.; Glaser, M.; Perumal, M.; Arstad, E.; Aboagye, E.O. Positron emission tomography imaging of druginduced tumor apoptosis with a caspase-3/7 specific [18F]-labeled isatin sulfonamide. Proc. Natl. Acad. Sci. USA, 2009, 106. 16375-80.
37. van Meer, G.; Voelker, D.R.; Feigenson, G.W. Membrane lipids: where they are and how they behave. Nat. Rev. Mol. Cell. Biol., 2008, 9. 112-124.
38. Bevers, E.M.; Comfurius, P.; Zwaal, R.F. Regulatory mechanisms in maintenance and modulation of transmembrane lipid asymmetry: pathophysiological implications. Lupus. 1996, 5. 480-487.
39. Sahu, S.K.; Gummadi, S.N.; Manoj, N.; Aradhyam, G.K. Phospholipid scramblases: an overview. Arch. Biochem. Biophys., 2007, 462. 103-114.
40. Bevers, E.M.; Comfurius, P.; Dekkers, D.W.; Harmsma, M.; Zwaal RF. Transmembrane phospholipid distribution in blood cells: control mechanisms and pathophysiological significance. Biol. Chem., 1998, 379, 973-986.
41. Qureshi, S.H.; Yang, L.; Manithody, C.; Rezaie, A.R. Membranedependent interaction of factor Xa and prothrombin with factor Va in the prothrombinase complex. Biochemistry. 2009, 48. 5034-5041.
42. Huang, M.; Rigby, A.C.; Morelli, X.; Grant, M.A.; Huang, G.; Furie, B.; Seaton, B.; Furie, B.C. Structural basis of membrane binding by Gla domains of vitamin K-dependent proteins. Nat. Struct. Biol., 2003, 10. 751-756.
43. Weber, D.J.; Pollock, J.S.; Pedersen, L.G.; Hiskey, R.G. The determination of a calcium-dependent binding constant of the bovine prothrombin Gla domain (residues 1-45) to phospholipid vesicles. Biochem. Biophys. Res. Commun., 1998, 155. 230-235.
44. Dachary-Prigent, J.; Toti, F.; Satta, N.; Pasquet, J.M.; Uzan, A.; Freyssinet, J.M. Physiopathological significance of catalytic phospholipids in the generation of thrombin. Semin Thromb Hemost., 1996, 22, 157-164.
45. Williamson, P.; Schlegel, R.A. Transbilayer phospholipid movement and the clearance of apoptotic cells. Biochim. Biophys. Acta., 2002, 1585. 53-63.
46. Miyanishi, M.; Tada, K.; Koike, M.; Uchiyama, Y.; Kitamura, T.; Nagata, S. Identification of Tim4 as a phosphatidylserine receptor. Nature, 2007, 450, 435-439.
47. Park, D.; Tosello-Trampont, A.C.; Elliott, M.R.; Lu, M.; Haney, L.B.; Ma, Z.; Klibanov, A.L.; Mandell, J.W.; Ravichandran, K.S. BAI1 is an engulfment receptor for apoptotic cells upstream of the ELMO/Dock180/Rac module. Nature, 2007, 450. 430-434.
48. Huber, R.; Römisch, J.; Paques, E.P. The crystal and molecular structure of human annexin V, an anticoagulant protein that binds to calcium and membranes. EMBO J., 1990, 9, 3867-3874.
49. Olofsson, A.; Mallouh, V.; Brisson, A. Two-dimensional structure of membrane-bound annexin V at 8 A resolution. J. Struct. Biol., 1994, 113. 199-205.
50. Huber, R.; Berendes, R.; Burger, A.; Schneider, M.; Karshikov, A.; Luecke, H.; Römisch, J.; Paques, E. Crystal and molecular structure of human annexin V after refinement. Implications for structure, membrane binding and ion channel formation of the annexin family of proteins. J. Mol. Biol., 1992, 223, 683-704.
51. Jin, M.; Smith, C.; Hsieh, H.Y.; Gibson, D.F.; Tait, J.F. Essential role of B-helix calcium binding sites in annexin V-membrane binding. J. Biol. Chem., 2004, 279. 40351-40357.
52. Narula, J.; Acio, E.R.; Narula, N.; Samuels, L.E.; Fyfe, B,; Wood, D.; Fitzpatrick, J.M.; Raghunath, P.N.; Tomaszewski, J.E.; Kelly, C.; Steinmetz, N.; Green, A.; Tait, J.F.; Leppo, J.; Blankenberg, F.G.; Jain, D.; Strauss, H.W. Annexin-V imaging for noninvasive detection of cardiac allograft rejection. Nat. Med., 2001, 7, 1347-1352.
53. Blankenberg, F.G.; Katsikis, P.D.; Tait, J.F.; Davis, R.E.; Naumovski, L.; Ohtsuki, K.; Kopiwoda, S.; Abrams, M.J.; Darkes, M,; Robbins, R.C.; Maecker, H, T.; Strauss, H.W. In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc. Natl. Acad. Sci. USA, 1998, 95. 6349-6354.
54. 99mTc recombinant human Annexin V in human tumors after one course of chemotherapy as a predictor of tumor response and patient prognosis. Clin. Cancer Res., 2002, 8. 2766-2774.
55. Thimister, P. W,; Hofstra, L.; Liem, I.H.; Boersma, H.H.; Kemerink, G.; Reutelingsperger, C.P.; Heidendal, G.A. In vivo detection of cell death in the area at risk in acute myocardial infarction. J. Nucl. Med., 2003, 44. 391-396.
56. Sosnovik, D.E.; Schellenberger, E.A.; Nahrendorf, M.; Novikov, M.S.; Matsui, T.; Dai, G.; Reynolds, F.; Grazette, L.; Rosenzweig, A.; Weissleder, R.; Josephson, L. Magnetic resonance imaging of cardiomyocyte apoptosis with a novel magneto-optical nanoparticle. Magn. Reson. Med., 2005, 54. 718-724.
57. Haas, R.L.; de Jong, D.; Valdés Olmos, R.A.; Hoefnagel, C.A.; van den Heuvel, I.; Zerp, S.F.; Bartelink, H.; Verheij, M. In vivo imaging of radiation-induced apoptosis in follicular lymphoma patients. Int. J. Oncol. Biol. Phys., 2004, 59. 782-787.
58. 99mTc-hydrazinonicotinamide-annexin V imaging for predicting response to chemotherapy. J. Nucl. Med. 2006, 47, 1813.
59. Li, X.; Link, J.M.; Stekhova, S.; Yagle, K.J.; Smith, C.; Krohn, K.A.; Tait, J.F. Site-specific labeling of annexin V with F-18 for apoptosis imaging. Bioconjug. Chem., 2008, 19. 1684-1688.
60. Tait, J.F.; Smith, C.; Gibson, D.F. Development of annexin V mutants suitable for labeling with Tc(i)-carbonyl complex. Bioconjug. Chem., 2002, 13, 1119-1123.
61. Gardzinski, P.; Lee, D.W.; Fei, G.H.; Hui, K.; Huang, G.J.; Sun, H.S.; Feng, Z.P. The role of synaptotagmin I C2A calcium-binding domain in synaptic vesicle clustering during synapse formation. J. Physiol., 2007, 581. 75-90.
62. Zhang, X.; Rizo, J.; Südhof, T.C. Mechanism of phospholipid binding by the C2A-domain of synaptotagmin I. Biochemistry. 1998, 37. 12395.
63. Sutton, R.B.; Davletov, B.A.; Berghuis, A.M.; Südhof, T.C.; Sprang, S.R. Structure of the first C2 domain of synaptotagmin I: a novel Ca2+/phospholipid-binding fold. Cell, 1995, 80. 929-938.
64. Davletov, B.A.; Südhof, T.C. A single C2 domain from synaptotagmin I is sufficient for high affinity Ca2+/phospholipid binding. J. Biol. Chem., 1993, 268. 26386-26390.
65. Jung, H.I.; Kettunen, M.I.; Davletov, B.; Brindle, K.M. Detection of apoptosis using the C2A domain of synaptotagmin I. Bioconjug. Chem., 2004, 15, 983-987.
66. Zhao, M.; Beauregard, D.A.; Loizou, L.; Davletov, B.; Brindle, K.M. Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent. Nat. Med., 2001, 7. 1241-1244.
67. 99mTc-labeled C2A domain of synaptotagmin I as a target-specific molecular probe for noninvasive imaging of acute myocardial infarction. J. Nucl. Med., 2006, 47, 1367-1374.
68. Liu, Z.; Zhao, M.; Zhu, X.; Furenlid, L.R.; Chen, Y.C.; Barrett, H.H. In vivo dynamic imaging of myocardial cell death using 99mTc-labeled C2A domain of synaptotagmin I in a rat model of ischemia and reperfusion. Nucl. Med. Biol., 2007, 34. 907-915.
69. Krishnan, A.S.; Neves, A.A.; de Backer, M.M.; Hu, D.E.; Davletov, B.; Kettunen, M.I.; Brindle, K.M. Detection of cell death in tumors by using MR imaging and a gadolinium-based targeted contrast agent. Radiology, 2008, 246. 854-862.
70. Smirnov, M.D.; Esmon, C.T. Phosphatidylethanolamine incorporation into vesicles selectively enhances factor Va inactivation by activated protein C. J. Biol. Chem., 1994, 269. 816-819.
71. Smirnov, M.D.; Triplett, D.T.; Comp, P.C.; Esmon, N.L.; Esmon, C.T. On the role of phosphatidylethanolamine in the inhibition of activated protein C activity by antiphospholipid antibodies. J. Clin. Invest., 1995, 95. 309-316.
72. Smirnov, M.D.; Safa, O.; Regan, L.; Mather, T.; Stearns-Kurosawa, D.J.; Kurosawa, S.; Rezaie, A.R.; Esmon, N.L.; Esmon, CT. A chimeric protein C containing the prothrombin Gla domain exhibits increased anticoagulant activity and altered phospholipid specificity. J. Biol. Chem., 1998, 273. 9031-9040.
73. Neuenschwander, P.F.; Bianco-Fisher, E.; Rezaie, A.R.; Morrissey, J.H. Phosphatidylethanolamine augments factor VIIa-tissue factor activity: enhancement of sensitivity to phosphatidylserine. Biochemistry, 1995, 34. 13988-13993.
74. Li, Z.; Wells, C.W.; Esmon, C.T.; Zhao, M. Phosphatidylethanolamine at the endothelial surface of aortic flow dividers. J. Thromb. Haemost. 2009, 7. 227-229.
75. Li, Z.; Wells, C.W.; North, P.E.; Kumar, S.; Duris, C.B.; McIntyre, J.A.; Zhao M. Phosphatidylethanolamine at the luminal endothelial surface: Implications in Hemostasis and thrombotic autoimmunity. Clin. Appl. Thromb. Hemost., 2009 Nov 10.
76. Emoto, K.; Toyama-Sorimachi, N.; Karasuyama, H.; Inoue, K.; Umeda, M. Exposure of phosphatidylethanolamine on the surface of apoptotic cells. Exp. Cell Res., 1997, 232. 430-434.
77. Hayash, i F.; Nagashima, K.; Terui, Y.; Kawamura, Y.; Matsumoto, K.; Itazaki, H. The structure of PA48009: the revised structure of duramycin. J. Antibiot., (Tokyo) 1990, 43, 1421-1430.
78. Seelig, J. Thermodynamics of lipid-peptide interactions. Biochim Biophys Acta. 2004, 1666. 40-50.
79. Zimmermann, N.; Freund, S.; Fredenhagen, A.; Jung, G. Solution structures of the lantibiotics duramycin B and C. Eur. J. Biochem., 1993, 216. 419-428.
80. Machaidze, G.; Ziegler, A. and Seelig, J. Specific binding of Ro 09-0198 (cinnamycin) to phosphatidylethanolamine: a thermodynamic analysis. Biochemistry. 2002, 41. 1965-1971.
81. Hosoda, K.; Ohya, M.; Kohno, T.; Maeda, T.; Endo, S.; Wakamatsu, K. Structure determination of an immunopotentiator peptide, cinnamycin, complexed with lysophosphatidylethanolamine by 1H-NMR1. J. Biochem., 1996, 119. 226-230.
82. Machaidze, G.; Seelig, J. Specific binding of cinnamycin (Ro 09-0198) to phosphatidylethanolamine. Comparison between micellar and membrane environments. Biochemistry. 2003, 42. 12570-12576.
83. Wakamatsu, K.; Choung, S.Y.; Kobayashi, T.; Inoue, K.; Higashijima, T.; Miyazawa, T. Complex formation of peptide antibiotic Ro09-0198 with lysophosphatidylethanolamine: 1H NMR analyses in dimethyl sulfoxide solution. Biochemistry. 1990, 29. 113-118.
84. 99mTc-labeled duramycin as a novel phosphatidylethanolamine-binding molecular probe. J. Nucl. Med., 2008, 49. 1345-1352.
85. Cohen, A.; Shirvan, A.; Levin, G.; Grimberg, H.; Reshef, A.; Ziv, I. From the Gla domain to a novel small-molecule detector of apoptosis. Cell Res., 2009, 19. 625-637.
86. Grimberg, H,; Levin, G.; Shirvan, A.; Cohen, A.; Yogev-Falach, M.; Reshef, A.; Ziv, I. Monitoring of tumor response to chemotherapy in vivo by a novel small-molecule detector of apoptosis. Apoptosis. 2009, 14. 257-267.
87. Aloya, R.; Shirvan, A.; Grimberg, H.; Reshef, A.; Levin, G.; Kidron, D.; Cohen, A.; Ziv, I. Molecular imaging of cell death in vivo by a novel small molecule probe. Apoptosis, 2006, 11. 2089-2101.